Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jansen

Showing results (181-190 of 664) with videos related to

Pageof 67
Sort By:
Health and Quality of Life Outcomes|July 4, 2014
Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysisJeroen P Jansen, Felicity Buckley, Fred Dejonckheere, et al.
Clinical Chemistry|July 1, 1977
Continuous-flow determination of serum inorganic phosphate with a single reagent--the vanadomolybdate method re-evaluatedH Baadenhuijsen, H E Seuren-Jacobs, A P Jansen
Oncogene|October 19, 1999
Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activationA P Jansen, N H Colburn, A K Verma
Journal of Pain and Symptom Management|August 29, 2013
A network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodesGiovambattista Zeppetella, Andrew Davies, Indra Eijgelshoven, et al.
HIV Clinical Trials|November 3, 2011
Comparative effectiveness of efavirenz, protease inhibitors, and raltegravir-based regimens as first-line treatment for HIV-infected adults: a mixed treatment comparisonMaria Cecilia Vieira, Ritesh N Kumar, Jeroen P Jansen
Statistical Methods in Medical Research|September 30, 2025
Augmented two-stage estimation for treatment switching in oncology trials: Leveraging external data for improved precisionHarlan Campbell, Nicholas Latimer, Jeroen P Jansen, et al.
Biochimica Et Biophysica Acta|July 18, 1986
Fatty acid-binding capacity of cytosolic proteins of various rat tissues: effect of postnatal development, starvation, sex, clofibrate feeding and light cycleR J Paulussen, G P Jansen, J H Veerkamp
Communications in Agricultural and Applied Biological Sciences|April 11, 2008
Pesticides selectivity list to beneficial arthropods in four field vegetable cropsL Hautier, J P Jansen, N Mabon, et al.
The Netherlands Journal of Medicine|January 1, 1973
Treatment of type II hyperlipoproteinaemia with cholestyramineR W Schade, Laar A van't, A P Jansen
The Journal of Liquid Biopsy|April 20, 2026
The potential survival gain and cost-effectiveness of circulating tumor DNA-guided treatment switching in advanced non-small cell lung cancer: A simulation modeling studyJeroen P Jansen, Michael P Douglas, Kathryn A Phillips
Pageof 67

Showing results (181-190 of 664) with videos related to

Sort By:
Pageof 67
Health and Quality of Life Outcomes|July 4, 2014
Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysisJeroen P Jansen, Felicity Buckley, Fred Dejonckheere, et al.
Clinical Chemistry|July 1, 1977
Continuous-flow determination of serum inorganic phosphate with a single reagent--the vanadomolybdate method re-evaluatedH Baadenhuijsen, H E Seuren-Jacobs, A P Jansen
Oncogene|October 19, 1999
Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activationA P Jansen, N H Colburn, A K Verma
Journal of Pain and Symptom Management|August 29, 2013
A network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodesGiovambattista Zeppetella, Andrew Davies, Indra Eijgelshoven, et al.
HIV Clinical Trials|November 3, 2011
Comparative effectiveness of efavirenz, protease inhibitors, and raltegravir-based regimens as first-line treatment for HIV-infected adults: a mixed treatment comparisonMaria Cecilia Vieira, Ritesh N Kumar, Jeroen P Jansen
Statistical Methods in Medical Research|September 30, 2025
Augmented two-stage estimation for treatment switching in oncology trials: Leveraging external data for improved precisionHarlan Campbell, Nicholas Latimer, Jeroen P Jansen, et al.
Biochimica Et Biophysica Acta|July 18, 1986
Fatty acid-binding capacity of cytosolic proteins of various rat tissues: effect of postnatal development, starvation, sex, clofibrate feeding and light cycleR J Paulussen, G P Jansen, J H Veerkamp
Communications in Agricultural and Applied Biological Sciences|April 11, 2008
Pesticides selectivity list to beneficial arthropods in four field vegetable cropsL Hautier, J P Jansen, N Mabon, et al.
The Netherlands Journal of Medicine|January 1, 1973
Treatment of type II hyperlipoproteinaemia with cholestyramineR W Schade, Laar A van't, A P Jansen
The Journal of Liquid Biopsy|April 20, 2026
The potential survival gain and cost-effectiveness of circulating tumor DNA-guided treatment switching in advanced non-small cell lung cancer: A simulation modeling studyJeroen P Jansen, Michael P Douglas, Kathryn A Phillips
Pageof 67